tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
aTyr Pharma (ATYR)
NASDAQ:ATYR
US Market
ATYR
aTyr Pharma
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

aTyr Pharma (ATYR) Stock News & Sentiment

Compare
2,083 Followers
Confident Buy Rating for aTyr Pharma Amidst Promising Phase 3 Study Insights
Premium
Ratings
Confident Buy Rating for aTyr Pharma Amidst Promising Phase 3 Study Insights
7d ago
ATYR
aTyr Pharma (ATYR) Stock Soars 24% on Promising Drug Developments
Premium
Market News
aTyr Pharma (ATYR) Stock Soars 24% on Promising Drug Developments
17d ago
ATYR
Buy Rating Affirmed for aTyr Pharma Amid Strategic Trial Adjustments and Financial Stability
Premium
Ratings
Buy Rating Affirmed for aTyr Pharma Amid Strategic Trial Adjustments and Financial Stability
18d ago
ATYR
aTyr Pharma’s Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
aTyr Pharma’s Earnings Call Highlights Progress and Challenges
20d ago
ATYR
Strategic Adjustments and Promising Developments Lead to Buy Rating for aTyr Pharma
Premium
Ratings
Strategic Adjustments and Promising Developments Lead to Buy Rating for aTyr Pharma
20d ago
ATYR
aTyr Pharma Reports 2024 Results and Strategic Progress
Premium
Company Announcements
aTyr Pharma Reports 2024 Results and Strategic Progress
21d ago
ATYR
aTyr Pharma: Attractive Buy Opportunity Amid Positive Phase 2 Data and Anticipated Phase 3 Catalysts
Premium
Ratings
aTyr Pharma: Attractive Buy Opportunity Amid Positive Phase 2 Data and Anticipated Phase 3 Catalysts
27d ago
ATYR
More ATYR News >

ATYR News on the Web

Piper Sandler Remains a Buy on aTyr Pharma (ATYR)
TipRanks News
Neutral
Insider Buying: Jane Gross Acquires Additional Shares of aTyr Pharma Inc (ATYR)
GuruFocus News
Neutral
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year?
Zacks
Neutral
aTyr Pharma Inc (ATYR) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ...
GuruFocus News
Neutral
Q4 2024 aTyr Pharma Inc Earnings Call Transcript
GuruFocus News
Neutral
aTyr Pharma Inc Reports Q4 2024 Earnings: EPS of -$0.18 Beats Estimates, Revenue at $0. ...
GuruFocus News
Neutral
ATyr Pharma's Efzofitimod Shows No Safety Concerns In Latest DSMB Review For Sarcoidosis Trial
rttnews
Neutral
aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
ATYR
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATYR’s Media Buzz Sentiment?
1 articles about ATYR were published this week. In an average week, 1.75 articles are published.
    What is ATYR’s weekly average amount of articles?
    In an average week, 1.75 articles about ATYR are published.
      What is ATYR’s News Sentiment?
      50% of articles about ATYR were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        GRIGRI Bio
        INMBInmune Bio
        HAWPFHaw Par
        OGNOrganon
        MRNAModerna
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing